J. Brange

发表

THE MEMORY OF A 2ND WW CAMP: 3D MODELING USING THE COMBINATION OF HYBRID TECHNOLOGIES

M. Koehl, S. Guillemin, M. Landolt, 2021 .

Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism.

V. Uversky, A. Fink, S. Frokjaer, 2001, Biochemistry.

Insulin structure and stability.

J. Brange, J. Brange, L. Langkjoer, 1993, Pharmaceutical biotechnology.

In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use

U. Ribel, A. Vølund, J. Schlichtkrull, 1991, Diabetic medicine : a journal of the British Diabetic Association.

Probing the mechanism of insulin fibril formation with insulin mutants.

V. Uversky, A. Fink, S. Frokjaer, 2001, Biochemistry.

Galenics of Insulin

J. Brange, 1987 .

Sequence-specific 1H-NMR assignments for the aromatic region of several biologically active, monomeric insulins including native human insulin.

M. Roy, M. Dunn, H. Thøgersen, 1990, Biochimica et biophysica acta.

1H NMR spectrum of the native human insulin monomer. Evidence for conformational differences between the monomer and aggregated forms.

M. Roy, M. Dunn, J. Brange, 1990, The Journal of biological chemistry.

Insulin Compatibility with Polymer Materials Used in External Pump Infusion Systems

S. Havelund, J. Brange, J. Villumsen, 1988, Diabetic medicine : a journal of the British Diabetic Association.

Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes

D. Owens, J. Vora, J. Brange, 1990, The Lancet.

Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

D. Owens, J. Vora, J. Brange, 1988, BMJ.

Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme.

J. Affholter, R. Roth, M. Bayne, 1990, Biochemistry.

Prediction of the association state of insulin using spectral parameters.

V. Uversky, A. Fink, I. Millett, 2003, Journal of pharmaceutical sciences.

Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy.

S. Frokjaer, J. Carpenter, J. Brange, 2001, Journal of pharmaceutical sciences.

The effect of mutations on the structure of insulin fibrils studied by Fourier transform infrared (FTIR) spectroscopy and electron microscopy.

S. Frokjaer, J. Carpenter, J. Brange, 2002, Journal of pharmaceutical sciences.

Chemical stability of insulin. 3. Influence of excipients, formulation, and pH.

J. Brange, L. Langkjaer, 1992, Acta pharmaceutica Nordica.

Absorption of Subcutaneously Infused Insulin: Influence of the Basal Rate Pulse Interval

J. Brange, C. Kühl, P. Hildebrandt, 1985, Diabetes Care.

Chemical stability of insulin. 5. Isolation, characterization and identification of insulin transformation products.

J. Brange, E. Sørensen, O. Hallund, 1992, Acta pharmaceutica Nordica.

Chemical stability of insulin. 4. Mechanisms and kinetics of chemical transformations in pharmaceutical formulation.

J. Brange, 1992, Acta pharmaceutica Nordica.

Insulin formulation and delivery.

J. Brange, L. Langkjaer, 1997, Pharmaceutical biotechnology.

Monomeric Insulins and Their Experimental and Clinical Implications

D R Owens, D. Owens, A. Vølund, 1990, Diabetes Care.

Toward understanding insulin fibrillation.

J. Brange, J Brange, L Andersen, 1997, Journal of pharmaceutical sciences.

Monomeric insulins obtained by protein engineering and their medical implications

J. Brange, U. Ribel, J. Brange, 1988, Nature.

Iontophoresis of monomeric insulin analogues in vitro: effects of insulin charge and skin pretreatment.

R. Guy, G. Grodsky, J. Brange, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Subcutaneous Insulin Absorption Explained by Insulin's Physicochemical Properties: Evidence From Absorption Studies of Soluble Human Insulin and Insulin Analogues in Humans

D R Owens, D. Owens, A. Vølund, 1991, Diabetes Care.

Comparison of Subcutaneous Soluble Human Insulin and Insulin Analogues (AspB9, GluB27; AspB10; AspB28) on Meal-Related Plasma Glucose Excursions in Type I Diabetic Subjects

D. Owens, A. Vølund, J. Peters, 1991, Diabetes Care.

Design of insulin analogues for meal-related therapy.

J. Brange, 1993, Journal of diabetes and its complications.

The new era of biotech insulin analogues

J. Brange, J. Brange, 1997, Diabetologia.

Sulfatide promotes the folding of proinsulin, preserves insulin crystals, and mediates its monomerization.

J. Whittingham, K. Buschard, J. Tranum-Jensen, 2001, Glycobiology.

Stability of Insulin

J. Brange, 1994 .

Production of Bovine and Porcine Insulin

J. Brange, 1987 .

Insulin analogs with improved pharmacokinetic profiles.

A. Vølund, J. Brange, Brange, 1999, Advanced drug delivery reviews.

Insulin analogues with improved absorption characteristics.

U. Ribel, J. Markussen, J. Brange, 1992, Hormone and metabolic research. Supplement series.

Characterization of Insulin

J. Brange, 1987 .

Stability of insulin : studies on the physical and chemical stability of insulin in pharmaceutical formulation

J. Brange, 1994 .

Absorption Kinetics and Action Profiles of Subcutaneously Administered Insulin Analogues (AspB9GluB27, AspB10, AspB28) in Healthy Subjects

D R Owens, D. Owens, A. Vølund, 1991, Diabetes Care.